The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Microneedle Flu Vaccine Market Research Report 2025
Synopsis
Micro-needles are new form of dose delivery systems, which can easily overcome various problems associated with the conventional formulations. Microneedle device consists of needles of micron size, which are arranged on a small dermal patch. The main principle of micro-needles include disruption of the skin layer, thus creating micron size pathway for drug delivery, in which the drugs can easily be transferred from epidermis or upper dermis region directly to the systemic circulation without facing any barrier. Micro-needles are of various types such as dissolving micro-needles, coated micro-needles, hollow micro-needles, and fabricated like solid micro-needles.
The global Microneedle Flu Vaccine market was valued at US$ 1422 million in 2023 and is anticipated to reach US$ 2036.6 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Microneedle Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microneedle Flu Vaccine.
Report Scope
The Microneedle Flu Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Microneedle Flu Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microneedle Flu Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
GC Pharma
Debiotech
NanoPass Technologies
Corium International
Becton Dickinson and Company
FluGen
CosMED Pharmaceuticals
Microdermics and OraSure Technologies
Segment by Type
Solid Microneedle
Hollow Microneedle
Coated Microneedle
Dissolving Microneedle
Segment by Application
Influenza A
Influenza B
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Microneedle Flu Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Microneedle Flu Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Micro-needles are new form of dose delivery systems, which can easily overcome various problems associated with the conventional formulations. Microneedle device consists of needles of micron size, which are arranged on a small dermal patch. The main principle of micro-needles include disruption of the skin layer, thus creating micron size pathway for drug delivery, in which the drugs can easily be transferred from epidermis or upper dermis region directly to the systemic circulation without facing any barrier. Micro-needles are of various types such as dissolving micro-needles, coated micro-needles, hollow micro-needles, and fabricated like solid micro-needles.
The global Microneedle Flu Vaccine market was valued at US$ 1422 million in 2023 and is anticipated to reach US$ 2036.6 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Microneedle Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microneedle Flu Vaccine.
Report Scope
The Microneedle Flu Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Microneedle Flu Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microneedle Flu Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
GC Pharma
Debiotech
NanoPass Technologies
Corium International
Becton Dickinson and Company
FluGen
CosMED Pharmaceuticals
Microdermics and OraSure Technologies
Segment by Type
Solid Microneedle
Hollow Microneedle
Coated Microneedle
Dissolving Microneedle
Segment by Application
Influenza A
Influenza B
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Microneedle Flu Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Microneedle Flu Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Microneedle Flu Vaccine Market Overview
1.1 Product Overview and Scope of Microneedle Flu Vaccine
1.2 Microneedle Flu Vaccine Segment by Type
1.2.1 Global Microneedle Flu Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Solid Microneedle
1.2.3 Hollow Microneedle
1.2.4 Coated Microneedle
1.2.5 Dissolving Microneedle
1.3 Microneedle Flu Vaccine Segment by Application
1.3.1 Global Microneedle Flu Vaccine Market Value by Application: (2024-2030)
1.3.2 Influenza A
1.3.3 Influenza B
1.4 Global Microneedle Flu Vaccine Market Size Estimates and Forecasts
1.4.1 Global Microneedle Flu Vaccine Revenue 2019-2030
1.4.2 Global Microneedle Flu Vaccine Sales 2019-2030
1.4.3 Global Microneedle Flu Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Microneedle Flu Vaccine Market Competition by Manufacturers
2.1 Global Microneedle Flu Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Microneedle Flu Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Microneedle Flu Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Microneedle Flu Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Microneedle Flu Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Microneedle Flu Vaccine, Product Type & Application
2.7 Microneedle Flu Vaccine Market Competitive Situation and Trends
2.7.1 Microneedle Flu Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Microneedle Flu Vaccine Players Market Share by Revenue
2.7.3 Global Microneedle Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Microneedle Flu Vaccine Retrospective Market Scenario by Region
3.1 Global Microneedle Flu Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Microneedle Flu Vaccine Global Microneedle Flu Vaccine Sales by Region: 2019-2030
3.2.1 Global Microneedle Flu Vaccine Sales by Region: 2019-2024
3.2.2 Global Microneedle Flu Vaccine Sales by Region: 2025-2030
3.3 Global Microneedle Flu Vaccine Global Microneedle Flu Vaccine Revenue by Region: 2019-2030
3.3.1 Global Microneedle Flu Vaccine Revenue by Region: 2019-2024
3.3.2 Global Microneedle Flu Vaccine Revenue by Region: 2025-2030
3.4 North America Microneedle Flu Vaccine Market Facts & Figures by Country
3.4.1 North America Microneedle Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Microneedle Flu Vaccine Sales by Country (2019-2030)
3.4.3 North America Microneedle Flu Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Microneedle Flu Vaccine Market Facts & Figures by Country
3.5.1 Europe Microneedle Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Microneedle Flu Vaccine Sales by Country (2019-2030)
3.5.3 Europe Microneedle Flu Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Microneedle Flu Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Microneedle Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Microneedle Flu Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Microneedle Flu Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Microneedle Flu Vaccine Market Facts & Figures by Country
3.7.1 Latin America Microneedle Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Microneedle Flu Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Microneedle Flu Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Microneedle Flu Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Microneedle Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Microneedle Flu Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Microneedle Flu Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Microneedle Flu Vaccine Sales by Type (2019-2030)
4.1.1 Global Microneedle Flu Vaccine Sales by Type (2019-2024)
4.1.2 Global Microneedle Flu Vaccine Sales by Type (2025-2030)
4.1.3 Global Microneedle Flu Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Microneedle Flu Vaccine Revenue by Type (2019-2030)
4.2.1 Global Microneedle Flu Vaccine Revenue by Type (2019-2024)
4.2.2 Global Microneedle Flu Vaccine Revenue by Type (2025-2030)
4.2.3 Global Microneedle Flu Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Microneedle Flu Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Microneedle Flu Vaccine Sales by Application (2019-2030)
5.1.1 Global Microneedle Flu Vaccine Sales by Application (2019-2024)
5.1.2 Global Microneedle Flu Vaccine Sales by Application (2025-2030)
5.1.3 Global Microneedle Flu Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Microneedle Flu Vaccine Revenue by Application (2019-2030)
5.2.1 Global Microneedle Flu Vaccine Revenue by Application (2019-2024)
5.2.2 Global Microneedle Flu Vaccine Revenue by Application (2025-2030)
5.2.3 Global Microneedle Flu Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Microneedle Flu Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Microneedle Flu Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GC Pharma
6.2.1 GC Pharma Corporation Information
6.2.2 GC Pharma Description and Business Overview
6.2.3 GC Pharma Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GC Pharma Microneedle Flu Vaccine Product Portfolio
6.2.5 GC Pharma Recent Developments/Updates
6.3 Debiotech
6.3.1 Debiotech Corporation Information
6.3.2 Debiotech Description and Business Overview
6.3.3 Debiotech Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Debiotech Microneedle Flu Vaccine Product Portfolio
6.3.5 Debiotech Recent Developments/Updates
6.4 NanoPass Technologies
6.4.1 NanoPass Technologies Corporation Information
6.4.2 NanoPass Technologies Description and Business Overview
6.4.3 NanoPass Technologies Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 NanoPass Technologies Microneedle Flu Vaccine Product Portfolio
6.4.5 NanoPass Technologies Recent Developments/Updates
6.5 Corium International
6.5.1 Corium International Corporation Information
6.5.2 Corium International Description and Business Overview
6.5.3 Corium International Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Corium International Microneedle Flu Vaccine Product Portfolio
6.5.5 Corium International Recent Developments/Updates
6.6 Becton Dickinson and Company
6.6.1 Becton Dickinson and Company Corporation Information
6.6.2 Becton Dickinson and Company Description and Business Overview
6.6.3 Becton Dickinson and Company Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Becton Dickinson and Company Microneedle Flu Vaccine Product Portfolio
6.6.5 Becton Dickinson and Company Recent Developments/Updates
6.7 FluGen
6.6.1 FluGen Corporation Information
6.6.2 FluGen Description and Business Overview
6.6.3 FluGen Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 FluGen Microneedle Flu Vaccine Product Portfolio
6.7.5 FluGen Recent Developments/Updates
6.8 CosMED Pharmaceuticals
6.8.1 CosMED Pharmaceuticals Corporation Information
6.8.2 CosMED Pharmaceuticals Description and Business Overview
6.8.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Portfolio
6.8.5 CosMED Pharmaceuticals Recent Developments/Updates
6.9 Microdermics and OraSure Technologies
6.9.1 Microdermics and OraSure Technologies Corporation Information
6.9.2 Microdermics and OraSure Technologies Description and Business Overview
6.9.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Portfolio
6.9.5 Microdermics and OraSure Technologies Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Microneedle Flu Vaccine Industry Chain Analysis
7.2 Microneedle Flu Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Microneedle Flu Vaccine Production Mode & Process
7.4 Microneedle Flu Vaccine Sales and Marketing
7.4.1 Microneedle Flu Vaccine Sales Channels
7.4.2 Microneedle Flu Vaccine Distributors
7.5 Microneedle Flu Vaccine Customers
8 Microneedle Flu Vaccine Market Dynamics
8.1 Microneedle Flu Vaccine Industry Trends
8.2 Microneedle Flu Vaccine Market Drivers
8.3 Microneedle Flu Vaccine Market Challenges
8.4 Microneedle Flu Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Microneedle Flu Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Microneedle Flu Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Microneedle Flu Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Microneedle Flu Vaccine Sales (K Dose) of Key Manufacturers (2019-2024)
Table 5. Global Microneedle Flu Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Microneedle Flu Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Microneedle Flu Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Microneedle Flu Vaccine Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Microneedle Flu Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Microneedle Flu Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Microneedle Flu Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Microneedle Flu Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Microneedle Flu Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microneedle Flu Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Microneedle Flu Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Microneedle Flu Vaccine Sales by Region (2019-2024) & (K Dose)
Table 18. Global Microneedle Flu Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Microneedle Flu Vaccine Sales by Region (2025-2030) & (K Dose)
Table 20. Global Microneedle Flu Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Microneedle Flu Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Microneedle Flu Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Microneedle Flu Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Microneedle Flu Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Microneedle Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Microneedle Flu Vaccine Sales by Country (2019-2024) & (K Dose)
Table 27. North America Microneedle Flu Vaccine Sales by Country (2025-2030) & (K Dose)
Table 28. North America Microneedle Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Microneedle Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Microneedle Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Microneedle Flu Vaccine Sales by Country (2019-2024) & (K Dose)
Table 32. Europe Microneedle Flu Vaccine Sales by Country (2025-2030) & (K Dose)
Table 33. Europe Microneedle Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Microneedle Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Microneedle Flu Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Microneedle Flu Vaccine Sales by Region (2019-2024) & (K Dose)
Table 37. Asia Pacific Microneedle Flu Vaccine Sales by Region (2025-2030) & (K Dose)
Table 38. Asia Pacific Microneedle Flu Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Microneedle Flu Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Microneedle Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Microneedle Flu Vaccine Sales by Country (2019-2024) & (K Dose)
Table 42. Latin America Microneedle Flu Vaccine Sales by Country (2025-2030) & (K Dose)
Table 43. Latin America Microneedle Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Microneedle Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Microneedle Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Microneedle Flu Vaccine Sales by Country (2019-2024) & (K Dose)
Table 47. Middle East & Africa Microneedle Flu Vaccine Sales by Country (2025-2030) & (K Dose)
Table 48. Middle East & Africa Microneedle Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Microneedle Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Microneedle Flu Vaccine Sales (K Dose) by Type (2019-2024)
Table 51. Global Microneedle Flu Vaccine Sales (K Dose) by Type (2025-2030)
Table 52. Global Microneedle Flu Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Microneedle Flu Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Microneedle Flu Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Microneedle Flu Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Microneedle Flu Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Microneedle Flu Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Microneedle Flu Vaccine Price (US$/Dose) by Type (2019-2024)
Table 59. Global Microneedle Flu Vaccine Price (US$/Dose) by Type (2025-2030)
Table 60. Global Microneedle Flu Vaccine Sales (K Dose) by Application (2019-2024)
Table 61. Global Microneedle Flu Vaccine Sales (K Dose) by Application (2025-2030)
Table 62. Global Microneedle Flu Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Microneedle Flu Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Microneedle Flu Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Microneedle Flu Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Microneedle Flu Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Microneedle Flu Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Microneedle Flu Vaccine Price (US$/Dose) by Application (2019-2024)
Table 69. Global Microneedle Flu Vaccine Price (US$/Dose) by Application (2025-2030)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Sanofi Microneedle Flu Vaccine Product
Table 74. Sanofi Recent Developments/Updates
Table 75. GC Pharma Corporation Information
Table 76. GC Pharma Description and Business Overview
Table 77. GC Pharma Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. GC Pharma Microneedle Flu Vaccine Product
Table 79. GC Pharma Recent Developments/Updates
Table 80. Debiotech Corporation Information
Table 81. Debiotech Description and Business Overview
Table 82. Debiotech Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. Debiotech Microneedle Flu Vaccine Product
Table 84. Debiotech Recent Developments/Updates
Table 85. NanoPass Technologies Corporation Information
Table 86. NanoPass Technologies Description and Business Overview
Table 87. NanoPass Technologies Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. NanoPass Technologies Microneedle Flu Vaccine Product
Table 89. NanoPass Technologies Recent Developments/Updates
Table 90. Corium International Corporation Information
Table 91. Corium International Description and Business Overview
Table 92. Corium International Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. Corium International Microneedle Flu Vaccine Product
Table 94. Corium International Recent Developments/Updates
Table 95. Becton Dickinson and Company Corporation Information
Table 96. Becton Dickinson and Company Description and Business Overview
Table 97. Becton Dickinson and Company Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. Becton Dickinson and Company Microneedle Flu Vaccine Product
Table 99. Becton Dickinson and Company Recent Developments/Updates
Table 100. FluGen Corporation Information
Table 101. FluGen Description and Business Overview
Table 102. FluGen Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. FluGen Microneedle Flu Vaccine Product
Table 104. FluGen Recent Developments/Updates
Table 105. CosMED Pharmaceuticals Corporation Information
Table 106. CosMED Pharmaceuticals Description and Business Overview
Table 107. CosMED Pharmaceuticals Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 108. CosMED Pharmaceuticals Microneedle Flu Vaccine Product
Table 109. CosMED Pharmaceuticals Recent Developments/Updates
Table 110. Microdermics and OraSure Technologies Corporation Information
Table 111. Microdermics and OraSure Technologies Description and Business Overview
Table 112. Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 113. Microdermics and OraSure Technologies Microneedle Flu Vaccine Product
Table 114. Microdermics and OraSure Technologies Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Microneedle Flu Vaccine Distributors List
Table 118. Microneedle Flu Vaccine Customers List
Table 119. Microneedle Flu Vaccine Market Trends
Table 120. Microneedle Flu Vaccine Market Drivers
Table 121. Microneedle Flu Vaccine Market Challenges
Table 122. Microneedle Flu Vaccine Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Microneedle Flu Vaccine
Figure 2. Global Microneedle Flu Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Microneedle Flu Vaccine Market Share by Type in 2023 & 2030
Figure 4. Solid Microneedle Product Picture
Figure 5. Hollow Microneedle Product Picture
Figure 6. Coated Microneedle Product Picture
Figure 7. Dissolving Microneedle Product Picture
Figure 8. Global Microneedle Flu Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Microneedle Flu Vaccine Market Share by Application in 2023 & 2030
Figure 10. Influenza A
Figure 11. Influenza B
Figure 12. Global Microneedle Flu Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Microneedle Flu Vaccine Market Size (2019-2030) & (US$ Million)
Figure 14. Global Microneedle Flu Vaccine Sales (2019-2030) & (K Dose)
Figure 15. Global Microneedle Flu Vaccine Average Price (US$/Dose) & (2019-2030)
Figure 16. Microneedle Flu Vaccine Report Years Considered
Figure 17. Microneedle Flu Vaccine Sales Share by Manufacturers in 2023
Figure 18. Global Microneedle Flu Vaccine Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Microneedle Flu Vaccine Players: Market Share by Revenue in 2023
Figure 20. Microneedle Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Microneedle Flu Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Microneedle Flu Vaccine Sales Market Share by Country (2019-2030)
Figure 23. North America Microneedle Flu Vaccine Revenue Market Share by Country (2019-2030)
Figure 24. United States Microneedle Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Microneedle Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Microneedle Flu Vaccine Sales Market Share by Country (2019-2030)
Figure 27. Europe Microneedle Flu Vaccine Revenue Market Share by Country (2019-2030)
Figure 28. Germany Microneedle Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Microneedle Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Microneedle Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Microneedle Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Microneedle Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Microneedle Flu Vaccine Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Microneedle Flu Vaccine Revenue Market Share by Region (2019-2030)
Figure 35. China Microneedle Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Microneedle Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Microneedle Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Microneedle Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Microneedle Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Microneedle Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Microneedle Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Microneedle Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Microneedle Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Microneedle Flu Vaccine Sales Market Share by Country (2019-2030)
Figure 45. Latin America Microneedle Flu Vaccine Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Microneedle Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Microneedle Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Microneedle Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Microneedle Flu Vaccine Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Microneedle Flu Vaccine Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Microneedle Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Microneedle Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Microneedle Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Microneedle Flu Vaccine by Type (2019-2030)
Figure 55. Global Revenue Market Share of Microneedle Flu Vaccine by Type (2019-2030)
Figure 56. Global Microneedle Flu Vaccine Price (US$/Dose) by Type (2019-2030)
Figure 57. Global Sales Market Share of Microneedle Flu Vaccine by Application (2019-2030)
Figure 58. Global Revenue Market Share of Microneedle Flu Vaccine by Application (2019-2030)
Figure 59. Global Microneedle Flu Vaccine Price (US$/Dose) by Application (2019-2030)
Figure 60. Microneedle Flu Vaccine Value Chain
Figure 61. Microneedle Flu Vaccine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
